What procedure code is applicable for a patient visit related to poison ivy treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Procedure Coding for Poison Ivy Treatment Visit

The appropriate procedure code for a patient visit related to poison ivy treatment would be an Evaluation and Management (E/M) code based on the complexity of the visit, typically ranging from 99202-99205 for new patients or 99212-99215 for established patients.

Determining the Appropriate E/M Code

The specific E/M code selection depends on several factors:

Level of Service Determination

  • History and Physical Examination: For poison ivy cases, document:

    • Distribution and severity of the rash
    • Presence of vesicles, papules, or bullae
    • Percentage of body surface area affected
    • Signs of secondary infection
    • Patient's allergic history to Toxicodendron species
  • Medical Decision Making: Based on:

    • Risk assessment (extent of rash, location, potential complications)
    • Data reviewed (if any previous treatments were attempted)
    • Number of diagnoses/treatment options considered

Typical Coding Scenarios

  1. Uncomplicated Poison Ivy (Limited Area)

    • Established patient: 99213
    • New patient: 99203
    • Characteristics: Localized rash, minimal systemic symptoms, straightforward treatment
  2. Moderate Poison Ivy (Larger Area/Face Involvement)

    • Established patient: 99214
    • New patient: 99204
    • Characteristics: More extensive rash, moderate discomfort, may require systemic steroids
  3. Severe Poison Ivy

    • Established patient: 99215
    • New patient: 99205
    • Characteristics: Extensive body involvement, severe symptoms, risk of complications, complex management decisions

Treatment Documentation to Support Coding

Document the following to support the selected code:

  • Immediate decontamination measures (if applicable)
  • Washing with soap and water or commercial decontamination products 1
  • Prescription of medications:
    • Topical treatments (noting limitations of OTC steroids) 1
    • Systemic corticosteroids (if prescribed, document duration - ideally 14+ days) 2
  • Patient education regarding:
    • Symptomatic relief measures (cool compresses, oatmeal baths) 1
    • Expected course of illness
    • Prevention strategies

Important Considerations

  • Treatment Duration: Document if prescribing systemic corticosteroids, noting that shorter courses (<14 days) are associated with increased return visits 2

  • Severity Assessment: Clearly document the extent and severity of symptoms as they directly impact the level of service provided

  • Follow-up Plans: Include any recommendations for follow-up visits if symptoms worsen or don't improve

  • Comorbidities: Note any relevant comorbidities that might affect treatment decisions

Coding Pitfalls to Avoid

  • Undercoding based on the presumed simplicity of poison ivy cases - remember that extensive cases may warrant higher-level codes
  • Failing to document the medical necessity for systemic treatments when prescribed
  • Not capturing the full extent of counseling provided regarding prevention and home care

Remember that poison ivy dermatitis affects approximately 50-75% of the US adult population 3 and can result in significant healthcare utilization when undertreated, so proper documentation and appropriate coding are essential for both patient care and practice reimbursement.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?

Dermatitis : contact, atopic, occupational, drug, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.